Geron Corporation

NASDAQ:GERN

Biotechnology

Healthcare
$0.91 +4.07%

+$0.05 today

Market cap
$588.19M
Beta
0.60
P/E (TTM)
-12.3
EPS (TTM)
-$0.10
52W Low $1.04High $2.01

Volume 19.64M

Average 16.28M

Price history

Geron Corporation SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-17.00%

Period high

$1.95

Period low

$0.89

Latest

$0.91

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
8-KNov 4, 2026Nov 4, 2026
10-QNov 4, 2026Nov 4, 2026
8-KOct 28, 2026Oct 28, 2026
4Oct 1, 2026Oct 1, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 7, 2026Aug 7, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 5, 2026Aug 5, 2026
S-8Aug 5, 2026Aug 5, 2026
4Jul 1, 2026Jul 1, 2026
8-KMay 27, 2026May 27, 2026
4May 26, 2026May 26, 2026
4May 26, 2026May 26, 2026
4May 26, 2026May 26, 2026

Competitors

Who does Geron Corporation compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about GERN's filings, answered from its disclosures.

What is the latest GERN filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does GERN have?

Intrinsic Alpha currently shows 20 recent filings for GERN.